Sex- and age-related variation in neurosteroidogenic enzyme mRNA levels during quail embryonic development

Expression of aromatase and two isozymes of 5α-reductase in the developing green anole forebrain

Neural steroids, as well as the enzymes that produce these hormones, are important for sexual differentiation of the brain during development. Aromatase converts testosterone into oestradiol. 5α-reductase converts testosterone to 5α-dihydrotestosterone and occurs in two isozymes: type 1 (5αR1) and type 2 (5αR2). Each of these enzymes is present in the developing brain in many species, although no work has been carried out examining the expression of all three enzymes in non-avian reptiles with genetic sex determination. In the present study, we evaluated mRNA expression of neural aromatase, 5αR1 and 5αR2, on the day of hatching and at day 50 in one such lizard, the green anole. We describe the distribution of these enzymes throughout the brain and the quantification of mRNA expression in three regions that control adult sexual behaviours: the preoptic area (POA) and ventromedial amygdala (AMY), which are involved in male displays, as well as the ventromedial hypothalamus, which regulates female receptivity. Younger animals had a greater number (POA) and density (AMY) of 5αR1 mRNA expressing cells. We detected no effects of sex or age on aromatase or 5αR2. In comparison with data from adults, the present results support the idea that the green anole forebrain has not completely differentiated by 50 days after hatching and that 5αR1 may play a role in the early development of regions important for masculine function.

Effect of gender, pregnancy and exposure conditions on metabolism and distribution of zearalenone in rats

The mycotoxin zearalenone (ZEA) is produced by a variety of Fusarium fungi and contaminates numerous cereals, fruits and vegetables. Interacting with the oestrogen receptors, ZEA and reduced metabolites zearalenols (ZOLs) cause hormonal effects in animals, such as abnormalities in the development of the reproductive tract and mammary gland in female offspring. Limited information is available on the pharmacokinetics of ZEA and its metabolites, particularly in pregnant females, foetuses and newborns. Our study was conducted to characterise the tissue distribution and metabolism of ZEA in male and female rats in various physiological states (virgin female, pregnant female) and exposure conditions (subcutaneous versus oral exposure, single versus repeated exposure to 1 mg/kg ZEA). Respective placental and mammary transfer to foetuses and newborns was evaluated. In all states and exposure conditions, α-ZOL and the glucuronides of ZEA and α-ZOL were the predominant metabolites, mostly concentrated in the intestine, the liver and the urine. Toxins were very low or undetectable in most of the tissues 24 h after ZEA exposure, except in foetal livers. Absorption and intestinal glucuronidation of ZEA were higher in males than females. α-ZOL concentration was significantly higher in the intestine and liver of males and pregnant females, compared to virgin females. ZEA and all its metabolites easily crossed the placental barrier and transferred into the milk. ZEA was metabolised in the foetal and neonatal stages, glucuronides being the main form detected in all organs. Metabolite elimination was slower in foetal tissues than in maternal tissues. All toxin concentrations in the foetal and neonatal tissues strongly increased in cases of repeated maternal exposure. A better knowledge of the metabolism and transfer of ZEA in foetuses and newborns will help to evaluate the health risk that such endocrine disruptors represent in these stages.

Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain

BACKGROUND

The mechanisms through which estrogens modulate neuronal physiology, brain morphology, and behavior in recent years have proven to be far more complex than previously thought. For example, a second nuclear estrogen receptor has been identified, a new family of coregulatory proteins regulating steroid-dependent gene transcriptions was discovered and, finally, it has become clear that estrogens have surprisingly rapid effects based on their actions on cell membranes, which in turn result in the modulation of intracellular signaling cascades.

SCOPE OF REVIEW

This paper presents a selective review of new findings in this area related to work in our laboratories, focusing on the role of estrogens in the activation of male sexual behavior. Two separate topics are considered. We first discuss functions of the steroid receptor coactivator-1 (SRC-1) that has emerged as a key limiting factor for behavioral effects of estradiol. Knocking-down its expression by antisense oligonucleotides drastically inhibits male-typical sexual behaviors. Secondly, we describe rapid regulations of brain estradiol production by calcium-dependent phosphorylations of the aromatase enzyme, themselves under the control of neurotransmitter activity.

MAJOR CONCLUSIONS

These rapid changes in estrogen bioavailability have clear behavioral consequences. Increases or decreases in estradiol concentrations respectively obtained by an acute injection of estradiol itself or of an aromatase inhibitor lead within 15-30 min to parallel changes in sexual behavior frequencies.

GENERAL SIGNIFICANCE

These new controls of estrogen action offer a vast array of possibilities for discrete local controls of estrogen action. They also represent a formidable challenge for neuroendocrinologists trying to obtain an integrated view of brain function in relation to behavior.

Cortisol and corticosterone in immune organs and brain of European starlings: developmental changes, effects of restraint stress, comparison with zebra finches

Glucocorticoids (GCs) are produced in the adrenal glands and also in extra-adrenal sites, including immune organs and brain. Here, we examined regulation of systemic GC levels in plasma and local GC levels in immune organs and brain during development. We conducted two studies and examined a total of 462 samples from 70 subjects. In study 1, we determined corticosterone and cortisol levels in the plasma, immune organs, and brain of wild European starlings on posthatch day 0 (P0) and P10 (at baseline and after 45 min of restraint). Baseline corticosterone and cortisol levels were low in the immune organs and brain at P0 and P10, providing little evidence for local GC synthesis in starlings. At P0, restraint had no significant effects on corticosterone or cortisol levels in the plasma or tissues; however, there was a trend for restraint to increase both corticosterone and cortisol in the immune organs. At P10, restraint increased corticosterone levels in the plasma and all tissues, but restraint increased cortisol levels in the plasma, thymus, and diencephalon only. In study 2, we directly compared GC levels in European starlings and zebra finches at P4. In zebra finches but not starlings, cortisol levels were higher in the immune organs than in plasma. This difference in immune GC levels might be due to evolutionary lineage, life history strategy, or experiential factors, such as parasite exposure. This is the first study to measure immune GC levels in wild animals and one of the first studies to measure local GC levels after restraint stress.